This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit September 23, 2015

Home   About   Join Us   Annual Conference   The Voice   Career Center   Resources   Education Plus  

 

Advaxis therapy improves survival rates in cervical cancer patients
Reuters
Advaxis Inc said its experimental cancer vaccine was found more effective in improving survival rates of cervical cancer patients than standard therapy, validating the technology behind its pipeline of cancer treatments. About 38.5 percent of the patients in a mid-stage study, whose disease had progressed or returned after prior therapy, survived for a year after being given the Advaxis vaccine, the biotech company said.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


ASCT/ASCT Services Exhibit at ASC 2015
ASCT
Make sure to stop by the ASCT Booth in the Exhibit Hall during the Nov. 13-16, 2015 ASC Annual Scientific Meeting in Chicago. Pick up a webinar schedule; order a Quality Assurance Center Module; renew your membership; and/or treat yourself to a tote bag, HPV plushy, microscope pin, notecards or playing cards. ASCT Executive Director Beth Denny will be at Booth #113.

ASCT Services, Inc. will be nearby in Booth #101. Stop by and learn more about joining ASCT Services' highly skilled laboratory survey teams. ASCT Services, Inc. directly impacts and improves patient care by upholding cytology CLIA regulations as well as individual laboratory standards and procedures. Learn more about this rewarding opportunity.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
UPCOMING EVENTS

Date Event Location More information

Oct. 20 EST

Atypical Squamous and Glandular Cells (ASC and AGC): The Cytologic Spectrum, Differential Interpretation and Management

Your PC
Fadi W. Abdul-Karim, MD, MMed
Professor and Vice Chair of Education
Christine Booth, MD
Associate Professor
Cleveland Clinic Lerner College of
Medicine at Case Western Reserve
University, Cleveland, Ohio

More info

Available for 6 months after subscribing

Quality Assessment Center (QAC) Cell Blocks Basics Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC) Document Control for Cytopathology Workbench

Your PC

Details

Available for 6 months after subscribing

Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench

Your PC

Details


INDUSTRY NEWS


Vaccine clears some precancerous cervical lesions in clinical trial
Medical Xpress
Scientists have used a genetically engineered vaccine to successfully eradicate high-grade precancerous cervical lesions in nearly one-half of women who received the vaccine in a clinical trial. The goal, say the scientists, was to find nonsurgical ways to treat precancerous lesions caused by HPV.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Missed an issue of ASCT Viewpoint? Click here to visit the ASCT Viewpoint archive page.


New mandate calls for HPV vaccination
The Brown Daily Herald
As the school year began, incoming seventh graders across the state bought backpacks, shopped for new clothes and dreaded the return of early morning wake-ups. This year, though, a new stop was added to the list — getting vaccinated against human papillomavirus, a sexually transmitted disease that can cause cervical cancer. The state began requiring the first dose of the vaccine of all seventh graders Aug. 1 after a mandate from the Rhode Island Department of Health. The second dose will be mandated for eighth graders beginning next year and the third for ninth graders the following year.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Understanding why some Latina women discontinue participation in cancer prevention outreach
Medical Xpress
It has long been known that rates of breast and cervical cancer screening among Latinas are low compared to rates for U.S. women overall. A study led by researchers at Roswell Park Cancer Institute (RPCI) found that age and fear of cancer diagnosis are among the reasons why Latina women do not continue participation following breast and cervical cancer education programs. The research was published in the Journal of Health Communication: International Perspectives.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORE NEWS


WHO: Risk of certain cancers is higher in transgender communities
QUARTZ
A July 2015 report published by the World Health Organization (WHO) highlights distinct health risks for the world’s transgender community. Of particular note is the measurably higher risk of cervical, ovarian, and uterine cancer faced by transgender men who retain genitalia they were born with. Due to stigma and social exclusion, many do not regularly receive gynecological examinations and concomitant cervical and ovarian screenings.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


The next big thing in cancer care
H&HN
Oncology is experiencing unprecedented change. Recent breakthroughs in immunotherapy have dramatically changed our view of what is possible. Patients who previously were on their deathbeds now have hope while others have experienced miraculous turnarounds in their prognoses.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 

ASCT Viewpoint
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Esther Cho, Content Editor, 469.420.2671   
Contribute news

This edition of ASCT Viewpoint was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
Sept. 9, 2015
Aug. 26, 2015
Aug. 12, 2015
July 22, 2015



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063